These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26559659)
1. Acetoxymethyl Ester of Tetrabromobenzimidazole-Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells. Viht K; Saaver S; Vahter J; Enkvist E; Lavogina D; Sinijärv H; Raidaru G; Guerra B; Issinger OG; Uri A Bioconjug Chem; 2015 Dec; 26(12):2324-35. PubMed ID: 26559659 [TBL] [Abstract][Full Text] [Related]
2. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. Leung KK; Shilton BH Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648 [TBL] [Abstract][Full Text] [Related]
3. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases. Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763 [TBL] [Abstract][Full Text] [Related]
4. Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2. Zien P; Duncan JS; Skierski J; Bretner M; Litchfield DW; Shugar D Biochim Biophys Acta; 2005 Dec; 1754(1-2):271-80. PubMed ID: 16203192 [TBL] [Abstract][Full Text] [Related]
5. The selectivity of inhibitors of protein kinase CK2: an update. Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507 [TBL] [Abstract][Full Text] [Related]
6. Development and exploitation of CK2 inhibitors. Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530 [TBL] [Abstract][Full Text] [Related]
7. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole. Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300 [TBL] [Abstract][Full Text] [Related]
8. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies. Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938 [TBL] [Abstract][Full Text] [Related]
9. Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential. Cozza G; Girardi C; Ranchio A; Lolli G; Sarno S; Orzeszko A; Kazimierczuk Z; Battistutta R; Ruzzene M; Pinna LA Cell Mol Life Sci; 2014 Aug; 71(16):3173-85. PubMed ID: 24442476 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives. Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404 [TBL] [Abstract][Full Text] [Related]
11. New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole. Bretner M; Najda-Bernatowicz A; Łebska M; Muszyńska G; Kilanowicz A; Sapota A Mol Cell Biochem; 2008 Sep; 316(1-2):87-9. PubMed ID: 18548199 [TBL] [Abstract][Full Text] [Related]
12. Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2. Gianoncelli A; Cozza G; Orzeszko A; Meggio F; Kazimierczuk Z; Pinna LA Bioorg Med Chem; 2009 Oct; 17(20):7281-9. PubMed ID: 19748274 [TBL] [Abstract][Full Text] [Related]
13. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873 [TBL] [Abstract][Full Text] [Related]
14. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach. Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657 [TBL] [Abstract][Full Text] [Related]
16. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1 Chojnacki K; Wińska P; Karatsai O; Koronkiewicz M; Milner-Krawczyk M; Wielechowska M; Rędowicz MJ; Bretner M; Borowiecki P Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200807 [TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro. Koronkiewicz M; Chilmonczyk Z; Kazimierczuk Z Anticancer Res; 2013 Nov; 33(11):4891-9. PubMed ID: 24222126 [TBL] [Abstract][Full Text] [Related]
19. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Duncan JS; Gyenis L; Lenehan J; Bretner M; Graves LM; Haystead TA; Litchfield DW Mol Cell Proteomics; 2008 Jun; 7(6):1077-88. PubMed ID: 18258654 [TBL] [Abstract][Full Text] [Related]
20. Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity. Cozza G; Zanin S; Sarno S; Costa E; Girardi C; Ribaudo G; Salvi M; Zagotto G; Ruzzene M; Pinna LA Biochem J; 2015 Nov; 471(3):415-30. PubMed ID: 26349539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]